Human Vitamin K Epoxide Reductase as a Target of Its Redox Protein.

blood coagulation conformational transition enzyme activation free energy landscape hVKORC1 human vitamin K epoxide reductase intrinsically disordered L-loop modelling modular protein molecular dynamics simulations redox protein target

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Mar 2022
Historique:
received: 14 03 2022
revised: 29 03 2022
accepted: 30 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

Human vitamin K epoxide reductase (hVKORC1) enzymatic activity requires an initial activation by a specific redox protein, a less studied step in the hVKORC1 vital cycle. Significant steric conditions must be met by enzymes, being that to adapt their configurations is mandatory for hVKORC1 activation. We studied, by molecular dynamics (MD) simulations, the folding and conformational plasticity of hVKORC1 in its inactive (fully oxidised) state using available structures, crystallographic and from de novo modelling. According to the obtained results, hVKORC1 is a modular protein composed of the stable transmembrane domain (TMD) and intrinsically disordered luminal (L) loop, possessing the great plasticity/adaptability required to perform various steps of the activation process. The docking (HADDOCK) of Protein Disulfide Isomerase (PDI) onto different hVKORC1 conformations clearly indicated that the most interpretable solutions were found on the target closed L-loop form, a prevalent conformation of hVKORC1's oxidised state. We also suggest that the cleaved L-loop is an appropriate entity to study hVKORC1 recognition/activation by its redox protein. Additionally, the application of hVKORC1 (membrane protein) in aqueous solution is likely to prove to be very useful in practice in either in silico studies or in vitro experiments.

Identifiants

pubmed: 35409257
pii: ijms23073899
doi: 10.3390/ijms23073899
pmc: PMC8998853
pii:
doi:

Substances chimiques

Vitamin K 12001-79-5
Vitamin K Epoxide Reductases EC 1.17.4.4
Protein Disulfide-Isomerases EC 5.3.4.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche (ANR)
ID : 18-CE20-0025-01

Références

Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
J Biol Chem. 2007 Jan 26;282(4):2626-35
pubmed: 17124179
J Chem Theory Comput. 2015 Aug 11;11(8):3584-3595
pubmed: 26300708
Antioxid Redox Signal. 2013 May 1;18(13):1623-41
pubmed: 23075118
Nature. 2004 Feb 5;427(6974):537-41
pubmed: 14765194
J Phys Chem B. 2008 Feb 28;112(8):2511-23
pubmed: 18237164
Nat Commun. 2021 Feb 11;12(1):958
pubmed: 33574233
Trends Cell Biol. 2001 Feb;11(2):82-8
pubmed: 11166216
Vitam Horm. 2008;78:23-33
pubmed: 18374188
J Org Chem. 2008 Jan 4;73(1):12-21
pubmed: 18052192
Vitam Horm. 2008;78:131-56
pubmed: 18374193
BMC Struct Biol. 2013 Oct 16;13:20
pubmed: 24131821
Protein Sci. 1999 Jun;8(6):1181-90
pubmed: 10386868
J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
Intrinsically Disord Proteins. 2013 Apr 1;1(1):e24157
pubmed: 28516007
Sci Rep. 2017 Aug 29;7(1):9858
pubmed: 28851879
J Mol Biol. 2005 Mar 4;346(4):1121-45
pubmed: 15701522
Vitam Horm. 2008;78:103-30
pubmed: 18374192
Biochim Biophys Acta. 2014 Feb;1840(2):838-46
pubmed: 23567800
J Thromb Haemost. 2008 May;6(5):797-803
pubmed: 18315553
Ann Nutr Metab. 2012;61(3):213-8
pubmed: 23183291
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Trends Biochem Sci. 2004 Jun;29(6):289-92
pubmed: 15276181
Science. 2021 Jan 1;371(6524):
pubmed: 33154105
Biochem J. 1992 Jan 1;281 ( Pt 1):255-9
pubmed: 1731762
Science. 1973 Jul 20;181(4096):223-30
pubmed: 4124164
Br J Nutr. 2021 Jul 28;126(2):191-198
pubmed: 33023681
FEBS Lett. 2012 Aug 14;586(17):2586-96
pubmed: 22710164
Bioinformatics. 2011 Jun 1;27(11):1575-7
pubmed: 21471012
J Chem Theory Comput. 2007 Nov;3(6):2312-34
pubmed: 26636222
Curr Protein Pept Sci. 2016;17(1):62-71
pubmed: 26412786
Annu Rep Comput Chem. 2017;13:231-278
pubmed: 29720925
Mol Biol (Mosk). 2008 Jul-Aug;42(4):701-6
pubmed: 18856071
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a013201
pubmed: 23637286
Adv Protein Chem. 2005;70:79-112
pubmed: 15837514
Biochem J. 2021 Jun 11;478(11):2035-2050
pubmed: 34101805
Int J Mol Sci. 2021 Jan 14;22(2):
pubmed: 33466919
Chem Rev. 2014 Jul 9;114(13):6557-60
pubmed: 25004990
J Phys Chem B. 2015 Apr 30;119(17):5386-91
pubmed: 25856548
Angew Chem Int Ed Engl. 2014 Feb 3;53(6):1548-51
pubmed: 24449148
J Chem Theory Comput. 2019 Dec 10;15(12):6752-6759
pubmed: 31647864
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15027-32
pubmed: 20696932
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Am J Clin Nutr. 2009 Oct;90(4):889-907
pubmed: 19692494
Antioxid Redox Signal. 2009 Nov;11(11):2807-50
pubmed: 19476414
Antioxid Redox Signal. 2009 May;11(5):1047-58
pubmed: 19014315
Foods. 2021 Dec 17;10(12):
pubmed: 34945687
Methods Mol Biol. 2015;1215:173-209
pubmed: 25330964
Biochim Biophys Acta. 2002 Feb 15;1570(1):27-32
pubmed: 11960685
Proteins. 2010 May 1;78(6):1339-75
pubmed: 20099310
J Mol Graph Model. 2001;19(1):26-59
pubmed: 11381529
Biochemistry. 2002 May 28;41(21):6573-82
pubmed: 12022860
J Phys Chem B. 2018 Dec 13;122(49):11807-11816
pubmed: 30362738
Protein Sci. 2002 Apr;11(4):739-56
pubmed: 11910019
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598

Auteurs

Julie Ledoux (J)

Centre Borelli, ENS Paris-Saclay, CNRS, Université Paris-Saclay, 4 Avenue Des Sciences, F-91190 Gif-sur-Yvette, France.

Maxim Stolyarchuk (M)

Centre Borelli, ENS Paris-Saclay, CNRS, Université Paris-Saclay, 4 Avenue Des Sciences, F-91190 Gif-sur-Yvette, France.

Enki Bachelier (E)

Centre Borelli, ENS Paris-Saclay, CNRS, Université Paris-Saclay, 4 Avenue Des Sciences, F-91190 Gif-sur-Yvette, France.

Alain Trouvé (A)

Centre Borelli, ENS Paris-Saclay, CNRS, Université Paris-Saclay, 4 Avenue Des Sciences, F-91190 Gif-sur-Yvette, France.

Luba Tchertanov (L)

Centre Borelli, ENS Paris-Saclay, CNRS, Université Paris-Saclay, 4 Avenue Des Sciences, F-91190 Gif-sur-Yvette, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH